Renovus Capital Partners-backed BlueRidge Life Sciences completed the acquisition of Design Science.

Renovus Capital Partners-backed BlueRidge Life Sciences, a specialized consulting and services platform, completed the acquisition of Design Science, a specialized human factors engineering and user-interface design consultancy. Financial terms were not disclosed. "This acquisition meaningfully expands BlueRidge’s capabilities across the product lifecycle. Human factors and usability engineering are increasingly critical to regulatory success, patient safety, and commercial adoption. Design Science brings exceptional talent, a strong culture, and a best-in-class scientific approach that complements our existing offerings and strengthens the value we deliver to clients," Ian Kelly, BlueRidge Life Sciences CEO.